Incident gout and weight change patterns: a retrospective cohort study of US adults
Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Ther...
Saved in:
Published in | Arthritis research & therapy Vol. 23; no. 1; pp. 69 - 9 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
02.03.2021
BioMed Central Ltd BMC |
Subjects | |
Online Access | Get full text |
ISSN | 1478-6362 1478-6354 1478-6362 |
DOI | 10.1186/s13075-021-02461-7 |
Cover
Abstract | Background
Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout.
Methods
Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated.
Results
Among our sample of adults aged 40–74 years at their midlife weight measure (
n
= 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08–3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19–2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0–6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2–44.9) cases could have been prevented during the 10 years.
Conclusions
Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. |
---|---|
AbstractList | Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Methods Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Results Among our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years. Conclusions Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Keywords: Gout, Weight change, Cohort Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Methods Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Results Among our sample of adults aged 40–74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08–3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19–2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0–6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2–44.9) cases could have been prevented during the 10 years. Conclusions Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Among our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years. Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Among our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years. Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Methods Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Results Among our sample of adults aged 40–74 years at their midlife weight measure ( n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08–3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19–2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0–6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2–44.9) cases could have been prevented during the 10 years. Conclusions Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout.BACKGROUNDAlthough the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout.Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated.METHODSUsing data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated.Among our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years.RESULTSAmong our sample of adults aged 40-74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08-3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19-2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0-6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2-44.9) cases could have been prevented during the 10 years.Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life.CONCLUSIONSGaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. Abstract Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to midlife and the different weight change patterns in specific age ranges on the incidence of gout in later life remain unknown. Therefore, we aimed to investigate the association between weight change patterns across adulthood and incident gout. Methods Using data from the National Health and Nutrition Examination Survey (NHANES), we categorized individuals into four weight change patterns: those who remained obese (stable obese), those who moved from a non-obese body mass index (BMI) to an obese BMI (gaining), those who moved from an obese BMI to a non-obese BMI (losing), and those who remained non-obese (stable non-obese). Incident gout reflected its occurrence over the 10-year follow-up from the recalled midlife weight measure to the time of this survey. Hazard ratios (HRs) and 95% confidence intervals relating weight change patterns to incident gout over the 10-year follow-up period were calculated using Cox models adjusted for covariates. The hypothetical population attributable fraction (PAF) for the weight change patterns was calculated. Results Among our sample of adults aged 40–74 years at their midlife weight measure (n = 11,079), 320 developed gout. The highest risk of incident gout was found for participants with the stable obese pattern (HR 1.84; 1.08–3.14) and not for participants who remained stable non-obese during adulthood. Moreover, gaining weight was a significant risk factor for incident gout (HR 1.65; 1.19–2.29). No significant associations were found between losing weight change patterns and the risk of gout during the study period. If participants who gained weight had become non-obese during the 10-year follow-up, an estimated 3.2% (95% CI 0–6.3) of observed gout cases could have been averted. In addition, if the population had maintained a normal BMI, 32.9% (95% CI 18.2–44.9) cases could have been prevented during the 10 years. Conclusions Gaining weight over adulthood was associated with an increased risk of gout. These findings have highlighted that maintaining non-obese weight and weight loss across adulthood is essential for the prevention and treatment of gout in adult life. |
ArticleNumber | 69 |
Audience | Academic |
Author | Newson, Roger B. Bai, Lu Cardoso, Marly Augusto Zhou, Tao Zhou, Jian-Bo |
Author_xml | – sequence: 1 givenname: Lu surname: Bai fullname: Bai, Lu organization: Hospice & Palliative Care Unit, Haidian Section of Peking University Third Hospital – sequence: 2 givenname: Jian-Bo orcidid: 0000-0003-2507-9192 surname: Zhou fullname: Zhou, Jian-Bo email: jbzhou@ccmu.edu.cn organization: Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University – sequence: 3 givenname: Tao surname: Zhou fullname: Zhou, Tao organization: School of Public Health (Shenzhen), Sun Yat-sen University – sequence: 4 givenname: Roger B. surname: Newson fullname: Newson, Roger B. organization: Department of Primary Care and Public Health, Imperial College London – sequence: 5 givenname: Marly Augusto surname: Cardoso fullname: Cardoso, Marly Augusto organization: Department of Nutrition, School of Public Health, University of Sao Paulo |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33653403$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktr3DAUhU1JaR7tH-iiCLrpxqkelix3UQihj4FAF2nWQr6SPRo80lSSU_Lvq8kk7UwowQiLq3M-ca_OaXXkg7dV9Zbgc0Kk-JgIwy2vMSVlNYLU7YvqhDStrAUT9Ghvf1ydprTCmNKONq-qY8YEZw1mJ9X1woMz1mc0hjkj7Q36bd24zAiW2o8WbXTONvr0CWkUbY4hbSxkd2sRhGWIGaU8mzsUBnRzjbSZp5xeVy8HPSX75uF_Vt18_fLz8nt99ePb4vLiqgaB21yzpjfEMi2YZiAGLhnV0LKuFLjthMSSEOg5YG4JhU7zbhhMzxpoqJGs1eysWuy4JuiV2kS31vFOBe3UfSHEUemYHUxW9VhT3RMwDRMN71ptpO0Z9GQAIaHDhfV5x9rM_doaKBOJejqAHp54t1RjuFVtRxknXQF8eADE8Gu2Kau1S2CnSXsb5qRo0wnKWkm30vdPpKswR19GpSjHVGDSyD3VqEsDzg-h3AtbqLoQnFNaaKKozv-jKp-xawclL4Mr9QPDu_1G_3b4GIkikDsBlLdO0Q4KXNbZhW3fblIEq2361C59qqRP3adPtcVKn1gf6c-a2M6UirgkLv6bxjOuP9FC6q0 |
CitedBy_id | crossref_primary_10_3390_healthcare9121639 crossref_primary_10_1186_s12889_024_20076_w crossref_primary_10_3390_medicina58121728 crossref_primary_10_4081_jbr_2024_12484 crossref_primary_10_1007_s11926_021_01020_y crossref_primary_10_1016_j_semarthrit_2022_152040 crossref_primary_10_1186_s12902_023_01447_7 crossref_primary_10_1007_s11596_023_2778_6 crossref_primary_10_1001_jamanetworkopen_2022_50674 crossref_primary_10_1186_s13063_024_08237_z crossref_primary_10_1016_j_jbspin_2024_105761 crossref_primary_10_1016_j_mmm_2021_07_008 crossref_primary_10_1093_rheumatology_keaf076 crossref_primary_10_3389_fimmu_2021_752359 crossref_primary_10_1007_s40520_024_02792_w crossref_primary_10_1002_art_42381 crossref_primary_10_3390_nu14173525 |
Cites_doi | 10.1111/j.1751-7176.2012.00674.x 10.1136/bmj.j1794 10.3899/jrheum.100418 10.1186/s12937-015-0032-1 10.1097/BOR.0000000000000366 10.1097/BOR.0b013e3282f4b1ed 10.1016/j.berh.2010.10.004 10.1136/annrheumdis-2017-211472 10.1136/bmj.39449.819271.BE 10.1371/journal.pone.0039321 10.1093/oxfordjournals.aje.a116777 10.1093/oxfordjournals.aje.a117252 10.1093/rheumatology/ket154 10.1001/jama.2016.6458 10.1056/NEJM198809223191216 10.1002/art.27338 10.1093/ajcn/53.6.1493 10.1097/00001648-199501000-00012 10.1002/art.23245 10.1136/annrheumdis-2016-209958 10.1007/s40292-014-0051-6 10.1016/j.rdc.2014.01.001 10.1042/cs0920051 10.1016/S0140-6736(16)00346-9 10.1038/nrrheum.2015.91 10.1002/acr.21772 10.3949/ccjm.73.12.1059 10.1080/10408398.2018.1503155 10.1093/rheumatology/keq256 10.1093/rheumatology/kez196 10.1016/j.amjmed.2011.11.018 10.1001/jama.2011.1169 10.1186/ar3272 10.2337/dc17-2336 10.1001/jama.2010.1638 10.1002/art.27667 10.1371/journal.pone.0051186 10.1007/s00394-014-0766-0 10.1016/S0026-0495(98)90346-8 10.3899/jrheum.160452 10.2105/AJPH.88.1.15 10.1136/annrheumdis-2013-203970 10.1136/annrheumdis-2015-208237 10.1001/jamanetworkopen.2019.17371 10.1159/000355405 10.1093/rheumatology/kex350 10.1002/acr.21824 10.1089/met.2009.0084 10.1093/ajcn/87.5.1480 10.1001/archinte.165.7.742 10.1093/oxfordjournals.epirev.a018000 10.1007/s11906-013-0344-5 10.1136/ard.59.7.539 10.1002/art.40159 10.1177/2040622315618393 10.1002/art.1780260115 |
ContentType | Journal Article |
Copyright | The Author(s) 2021 COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2021 – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s13075-021-02461-7 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1478-6362 |
EndPage | 9 |
ExternalDocumentID | oai_doaj_org_article_b0a2ab1cd4364597ad8eb3cb1fc68c90 PMC7923519 A655222376 33653403 10_1186_s13075_021_02461_7 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | United States United States--US |
GeographicLocations_xml | – name: United States – name: United States--US |
GrantInformation_xml | – fundername: the National Natural Science Foundation of China grantid: 81870556, 81670738 – fundername: ; grantid: 81870556, 81670738 |
GroupedDBID | --- .GJ 0R~ 23N 2WC 4.4 5GY 5VS 6J9 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABUWG ACGFS ACJQM ADBBV ADUKV AEGXH AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK E3Z EBD EBLON EMOBN F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE HZ~ INH INR ITC KQ8 M1P O5R O5S O9- PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ ROL RPM RSV SMD SOJ SV3 TR2 U2A UKHRP WOQ AAYXX ALIPV CITATION NPM PMFND 3V. 7XB 8FK AZQEC DWQXO K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c607t-34bd1e3a63a3c6f5832ac739a635e9680811cb5c05e12c9a59ffdb34c42d837a3 |
IEDL.DBID | DOA |
ISSN | 1478-6362 1478-6354 |
IngestDate | Wed Aug 27 01:15:55 EDT 2025 Thu Aug 21 18:16:56 EDT 2025 Fri Sep 05 14:56:55 EDT 2025 Fri Jul 25 05:04:44 EDT 2025 Tue Jun 17 20:53:45 EDT 2025 Tue Jun 10 20:28:13 EDT 2025 Thu Apr 03 07:04:03 EDT 2025 Tue Jul 01 04:00:56 EDT 2025 Thu Apr 24 22:53:43 EDT 2025 Sat Sep 06 07:28:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Cohort Gout Weight change |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c607t-34bd1e3a63a3c6f5832ac739a635e9680811cb5c05e12c9a59ffdb34c42d837a3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0003-2507-9192 |
OpenAccessLink | https://doaj.org/article/b0a2ab1cd4364597ad8eb3cb1fc68c90 |
PMID | 33653403 |
PQID | 2502601489 |
PQPubID | 42876 |
PageCount | 9 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_b0a2ab1cd4364597ad8eb3cb1fc68c90 pubmedcentral_primary_oai_pubmedcentral_nih_gov_7923519 proquest_miscellaneous_2496237829 proquest_journals_2502601489 gale_infotracmisc_A655222376 gale_infotracacademiconefile_A655222376 pubmed_primary_33653403 crossref_citationtrail_10_1186_s13075_021_02461_7 crossref_primary_10_1186_s13075_021_02461_7 springer_journals_10_1186_s13075_021_02461_7 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-03-02 |
PublicationDateYYYYMMDD | 2021-03-02 |
PublicationDate_xml | – month: 03 year: 2021 text: 2021-03-02 day: 02 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Arthritis research & therapy |
PublicationTitleAbbrev | Arthritis Res Ther |
PublicationTitleAlternate | Arthritis Res Ther |
PublicationYear | 2021 |
Publisher | BioMed Central BioMed Central Ltd BMC |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
References | V Casey (2461_CR60) 1991; 53 G Singh (2461_CR2) 2019; 58 JS Sundy (2461_CR57) 2011; 306 A Dagfifinn (2461_CR33) 2014; 53 HK Choi (2461_CR54) 2010; 304 SK Rai (2461_CR12) 2017; 357 JD FitzGerald (2461_CR51) 2020; 0 R Villegas (2461_CR38) 2010; 8 A Must (2461_CR63) 1993; 138 JA Bernal (2461_CR6) 2016; 7 CF Kuo (2461_CR11) 2015; 11 LA Joosten (2461_CR43) 2010; 62 RJ Glynn (2461_CR37) 1983; 26 N Delbeth (2461_CR10) 2016; 388 JD Sorkin (2461_CR62) 1999; 21 EU Smith (2461_CR1) 2010; 24 N Dalbeth (2461_CR34) 2014; 73 JW Maynard (2461_CR19) 2012; 125 A Shiozawa (2461_CR46) 2017; 44 B Rockhill (2461_CR25) 1998; 88 K Chaudhary (2461_CR50) 2013; 3 U Kiltz (2461_CR8) 2016; 76 S Wacholder (2461_CR26) 1994; 140 JC Ter Maaten (2461_CR15) 1997; 92 L Cea Soriano (2461_CR18) 2011; 13 D Khanna (2461_CR16) 2012; 64 LE Peter (2461_CR29) 2018; 20 NW McGill (2461_CR41) 2011; 3 HK Choi (2461_CR53) 2008; 336 Z Soltani (2461_CR48) 2013; 15 PT Williams (2461_CR52) 2008; 87 R Heaney (2461_CR64) 1988; 319 KM Flegal (2461_CR27) 2016; 315 S Yamashita (2461_CR39) 1986; 10 G Jia (2461_CR28) 2019; 2 B Gao (2461_CR45) 2012; 7 JH Chen (2461_CR21) 2013; 65 C Maglio (2461_CR35) 2016; 76 F Matsuura (2461_CR44) 1998; 47 S Ebrahimpour-Koujan (2461_CR13) 2020; 60 T Neogi (2461_CR4) 2015; 74 MC Cleophas (2461_CR42) 2017; 29 T Lyngdoh (2461_CR49) 2012; 7 HK Choi (2461_CR30) 2005; 165 JW Choi (2461_CR55) 2008; 59 A Strokes (2461_CR23) 2018; 41 2461_CR22 V Bhole (2461_CR17) 2010; 62 N Dalbeth (2461_CR3) 2013; 52 PH Dessein (2461_CR32) 2000; 59 CA Scire (2461_CR5) 2013; 15 SM Nielsen (2461_CR36) 2017; 76 JG Puig (2461_CR31) 2008; 20 M McAdams (2461_CR65) 2011; 38 AK Tausche (2461_CR58) 2017; 56 N Dalbeth (2461_CR59) 2017; 69 GS Perry (2461_CR61) 1995; 6 E Roddy (2461_CR9) 2014; 40 Y Yuan (2461_CR24) 2011; 45 2461_CR56 D Grassi (2461_CR7) 2014; 21 M Heinig (2461_CR47) 2006; 73 Y Zhu (2461_CR40) 2010; 49 2461_CR14 MA McAdams-DeMarco (2461_CR20) 2012; 14 |
References_xml | – volume: 14 start-page: 675 year: 2012 ident: 2461_CR20 publication-title: J Clin Hypertens (Greenwich) doi: 10.1111/j.1751-7176.2012.00674.x – volume: 357 start-page: j1794 year: 2017 ident: 2461_CR12 publication-title: BMJ doi: 10.1136/bmj.j1794 – volume: 38 start-page: 135 year: 2011 ident: 2461_CR65 publication-title: J Rheumatol doi: 10.3899/jrheum.100418 – ident: 2461_CR56 doi: 10.1186/s12937-015-0032-1 – volume: 29 start-page: 163 year: 2017 ident: 2461_CR42 publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0000000000000366 – volume: 20 start-page: 187 year: 2008 ident: 2461_CR31 publication-title: Curr Opin Rheumatol doi: 10.1097/BOR.0b013e3282f4b1ed – volume: 24 start-page: 811 year: 2010 ident: 2461_CR1 publication-title: Best Pract Res Clin Rheumatol doi: 10.1016/j.berh.2010.10.004 – volume: 76 start-page: 1870 year: 2017 ident: 2461_CR36 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-211472 – volume: 336 start-page: 309 issue: 7639 year: 2008 ident: 2461_CR53 publication-title: BMJ (Clinical Research Ed) doi: 10.1136/bmj.39449.819271.BE – volume: 7 year: 2012 ident: 2461_CR49 publication-title: PLoS One doi: 10.1371/journal.pone.0039321 – volume: 138 start-page: 56 issue: 1 year: 1993 ident: 2461_CR63 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a116777 – volume: 140 start-page: 303 year: 1994 ident: 2461_CR26 publication-title: Am J Epidemiol doi: 10.1093/oxfordjournals.aje.a117252 – volume: 52 start-page: 1748 year: 2013 ident: 2461_CR3 publication-title: Rheumatology doi: 10.1093/rheumatology/ket154 – volume: 315 start-page: 2284 issue: 21 year: 2016 ident: 2461_CR27 publication-title: JAMA doi: 10.1001/jama.2016.6458 – volume: 319 start-page: 795 issue: 12 year: 1988 ident: 2461_CR64 publication-title: N Engl J Med doi: 10.1056/NEJM198809223191216 – volume: 62 start-page: 1069 year: 2010 ident: 2461_CR17 publication-title: Arthritis Rheum doi: 10.1002/art.27338 – volume: 20 start-page: 1301 year: 2018 ident: 2461_CR29 publication-title: Arthritis Res Ther – volume: 53 start-page: 1493 year: 1991 ident: 2461_CR60 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/53.6.1493 – volume: 6 start-page: 61 year: 1995 ident: 2461_CR61 publication-title: Epidemiology doi: 10.1097/00001648-199501000-00012 – volume: 59 start-page: 109 year: 2008 ident: 2461_CR55 publication-title: Arthritis Rheum doi: 10.1002/art.23245 – volume: 15 start-page: R101 year: 2013 ident: 2461_CR5 publication-title: Res Ther – volume: 76 start-page: 688 year: 2016 ident: 2461_CR35 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209958 – volume: 21 start-page: 243 year: 2014 ident: 2461_CR7 publication-title: High Blood Press Cardiovasc Prev doi: 10.1007/s40292-014-0051-6 – volume: 40 start-page: 155 year: 2014 ident: 2461_CR9 publication-title: Rheum Dis Clin N Am doi: 10.1016/j.rdc.2014.01.001 – volume: 92 start-page: 51 year: 1997 ident: 2461_CR15 publication-title: Clin Sci (Lond) doi: 10.1042/cs0920051 – ident: 2461_CR22 – volume: 0 start-page: 1 year: 2020 ident: 2461_CR51 publication-title: Arthritis Care Res – volume: 388 start-page: 2039 year: 2016 ident: 2461_CR10 publication-title: Lancet doi: 10.1016/S0140-6736(16)00346-9 – volume: 11 start-page: 649 year: 2015 ident: 2461_CR11 publication-title: Nat Rev Rheumatol doi: 10.1038/nrrheum.2015.91 – volume: 64 start-page: 1431 year: 2012 ident: 2461_CR16 publication-title: Arthritis Care Res doi: 10.1002/acr.21772 – volume: 73 start-page: 1059 year: 2006 ident: 2461_CR47 publication-title: Cleve Clin J Med doi: 10.3949/ccjm.73.12.1059 – volume: 60 start-page: 1 year: 2020 ident: 2461_CR13 publication-title: Crit Rev Food Sci Nutr doi: 10.1080/10408398.2018.1503155 – volume: 49 start-page: 2391 year: 2010 ident: 2461_CR40 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/keq256 – volume: 58 start-page: 2177 year: 2019 ident: 2461_CR2 publication-title: Rheumatology doi: 10.1093/rheumatology/kez196 – volume: 125 start-page: 717. e9 year: 2012 ident: 2461_CR19 publication-title: Am J Med doi: 10.1016/j.amjmed.2011.11.018 – volume: 306 start-page: 711 year: 2011 ident: 2461_CR57 publication-title: JAMA doi: 10.1001/jama.2011.1169 – volume: 13 start-page: R39 year: 2011 ident: 2461_CR18 publication-title: Arthritis Res Ther doi: 10.1186/ar3272 – volume: 41 start-page: 1025 issue: 5 year: 2018 ident: 2461_CR23 publication-title: Diabetes Care doi: 10.2337/dc17-2336 – volume: 304 start-page: 2270 year: 2010 ident: 2461_CR54 publication-title: JAMA doi: 10.1001/jama.2010.1638 – volume: 62 start-page: 3237 year: 2010 ident: 2461_CR43 publication-title: Arthritis Rheum doi: 10.1002/art.27667 – volume: 7 year: 2012 ident: 2461_CR45 publication-title: PLoS One doi: 10.1371/journal.pone.0051186 – volume: 53 start-page: 1591 year: 2014 ident: 2461_CR33 publication-title: Eur J Nutr doi: 10.1007/s00394-014-0766-0 – volume: 47 start-page: 929 year: 1998 ident: 2461_CR44 publication-title: Metabolism doi: 10.1016/S0026-0495(98)90346-8 – volume: 44 start-page: 388 year: 2017 ident: 2461_CR46 publication-title: J Rheumatol doi: 10.3899/jrheum.160452 – volume: 88 start-page: 15 year: 1998 ident: 2461_CR25 publication-title: Am J Public Health doi: 10.2105/AJPH.88.1.15 – volume: 73 start-page: 797 year: 2014 ident: 2461_CR34 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2013-203970 – volume: 45 start-page: 1 year: 2011 ident: 2461_CR24 publication-title: J StatSoftw – volume: 74 start-page: 1789 year: 2015 ident: 2461_CR4 publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2015-208237 – volume: 2 start-page: e1917371 year: 2019 ident: 2461_CR28 publication-title: JAMA Network Open doi: 10.1001/jamanetworkopen.2019.17371 – volume: 10 start-page: 255 year: 1986 ident: 2461_CR39 publication-title: Int J Obes – ident: 2461_CR14 – volume: 3 start-page: 208 year: 2013 ident: 2461_CR50 publication-title: Cardiorenal Med doi: 10.1159/000355405 – volume: 56 start-page: 2170 year: 2017 ident: 2461_CR58 publication-title: Rheumatology (Oxford) doi: 10.1093/rheumatology/kex350 – volume: 65 start-page: 133 year: 2013 ident: 2461_CR21 publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.21824 – volume: 8 start-page: 263 year: 2010 ident: 2461_CR38 publication-title: Metab Syndr Relat Disord doi: 10.1089/met.2009.0084 – volume: 87 start-page: 1480 year: 2008 ident: 2461_CR52 publication-title: Am J Clin Nutr doi: 10.1093/ajcn/87.5.1480 – volume: 165 start-page: 742 year: 2005 ident: 2461_CR30 publication-title: Arch Intern Med doi: 10.1001/archinte.165.7.742 – volume: 76 start-page: 1 year: 2016 ident: 2461_CR8 publication-title: Ann Rheum Dis – volume: 3 start-page: 73 year: 2011 ident: 2461_CR41 publication-title: Open Access Rheumatol Res Rev – volume: 21 start-page: 247 issue: 2 year: 1999 ident: 2461_CR62 publication-title: Epidemiol Rev doi: 10.1093/oxfordjournals.epirev.a018000 – volume: 15 start-page: 175 year: 2013 ident: 2461_CR48 publication-title: Curr Hypertens Rep doi: 10.1007/s11906-013-0344-5 – volume: 59 start-page: 539 year: 2000 ident: 2461_CR32 publication-title: Ann Rheum Dis doi: 10.1136/ard.59.7.539 – volume: 69 start-page: 1903 year: 2017 ident: 2461_CR59 publication-title: Arthritis Rheumatol doi: 10.1002/art.40159 – volume: 7 start-page: 135 year: 2016 ident: 2461_CR6 publication-title: Ther Adv Chronic Dis doi: 10.1177/2040622315618393 – volume: 26 start-page: 87 year: 1983 ident: 2461_CR37 publication-title: Arthritis Rheum doi: 10.1002/art.1780260115 |
SSID | ssj0022924 |
Score | 2.4381886 |
Snippet | Background
Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early... Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early adulthood to... Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from early... Abstract Background Although the relationship between obesity and incident gout has been clarified, the influence of weight changes during the transition from... |
SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 69 |
SubjectTerms | Adults Age Analysis Arthritis Body size Cohort Cohort analysis Complications and side effects Diabetes Gout Health aspects Hypertension Hypotheses Investigations Medicine Medicine & Public Health Obesity Orthopedics Population Research Article Rheumatism Rheumatology Risk factors Weight change Weight control |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Ni9QwFA-6gngRv-26SgTBg5ZtmzRpvMgqLouwXtaBuYUkTVdB2rHtsP--76XpjF1xD700r6Xp-07yfo-QN-DhnIUwIuWmNCm3SqXWW9ArBQl2IZhoBNYOn38TZyv-dV2u44LbEI9VzjYxGOq6c7hGfgyuGtGveKU-bn6n2DUKd1djC43b5E6ALgN5lut9wlWoqakth0wJHCufi2YqcTyA7ZZYmwzJNEKqpXLhmAJ-_79W-i83df0I5bV91OCeTh-Q-zGupCeTIDwkt3z7iNw9jzvnj8kFGALsHzrSy247UtPW9CqsitKp9JduAtBmO3yghvZ-7Lu5BpNiD91-pAGIlnYNXV3QgNoxPCGr0y_fP5-lsaFC6kQmx5RxW-eeGcEMc6IpQZuNk0zBjdKr0IQjB865rPR54ZQpVdPUlnHHixoSWcOekoO2a_1zQsEuSK6yxrpCwVsb09QcCCC5s3iJhOTz39Quoo1j04tfOmQdldATBzRwQAcOaJmQd7tnNhPWxo3Un5BJO0rEyQ43uv5SR7XTNjOFsbmrOW63KmnqylvmbN44UTmVJeQtslijNsPnOROLEmCSiIulT0RZYgQlYUJHC0rQQrccnoVERysw6L3MJuT1bhifxJNtre-2QMMVRKAQpwHNs0mmdlNiTJSMZywhciFtizkvR9qfPwJGOMJCQnCekPezXO4_6___9PDmWbwg94qgMbj1f0QOxn7rX0JMNtpXQfH-AFqrL8Q priority: 102 providerName: ProQuest – databaseName: SpringerLink Journals (ICM) dbid: U2A link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Li9YwEA-6gngR12d1XSIIHrTYNq_G2-eyyyKsl_WDvYUkTdcFaZe2H_77zqQP7foAD700k9J08ktmOpnfEPIadjjvwIxIuRU25U7r1AUHuNLgYBeSyVpi7vDZZ3m65Z8uxMWUFNbPp93nkGRcqSOsS_m-h9VWYTYxuL9Igpaq2-SOAN8d4bgtNoubVYBLMafH_LHfaguKTP2_r8e_bEg3D0veiJjGjejkAbk_WZB0M6p8n9wKzUNy92yKkT8i5wB5rBQ60Mt2N1DbVPR7_P9JxyRfeh0pNZv-A7W0C0PXztmWFKvldgONlLO0ren2nEZ-jv4x2Z4cfzk6TafSCamXmRpSxl2VB2Yls8zLWgBurVdMww0RdCy3kYOOfCZCXnhtha7ryjHueVGBy2rZE7LXtE14RiisAIrrrHa-0PDU2tYVBwFw4xxeMiH5_DWNn3jFsbzFNxP9i1KaUQMGNGCiBoxKyNulz_XIqvFP6Y-opEUSGbHjjba7NBPAjMtsYV3uK46BVa1sVQbHvMtrL0uvs4S8QRUbxC28nrdT-gEMEhmwzEYKgbaSggEdrCQBb37dPE8SM-G9N2BIIjcbL3VCXi3N2BPPsDWh3YEM12BrgkUGMk_HObUMiTEpGM9YQtRqtq3GvG5prr5GNnAkgAQzPCHv5nn587X-_k2f_5_4C3KviAjCoP8B2Ru6XXgJ1tjgDiP4fgAKqSrV priority: 102 providerName: Springer Nature |
Title | Incident gout and weight change patterns: a retrospective cohort study of US adults |
URI | https://link.springer.com/article/10.1186/s13075-021-02461-7 https://www.ncbi.nlm.nih.gov/pubmed/33653403 https://www.proquest.com/docview/2502601489 https://www.proquest.com/docview/2496237829 https://pubmed.ncbi.nlm.nih.gov/PMC7923519 https://doaj.org/article/b0a2ab1cd4364597ad8eb3cb1fc68c90 |
Volume | 23 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3fi9QwEB70BPHl8LfVc4kg-KDl2iZNGt_2ljsO4Q7xXNi3kKTtKUh77Ha5f9-ZtF2vJ-qLD7uwzbQkmZlmvk3mG4C3uMJ5h2FELGxuY-G0jl3l0K80AuxMcllLyh0-O5enS_Fpla9ulPqiM2E9PXA_cYcusZl1qS8FbZhpZcsC8Z93ae1l4XVA64lORjA1QK0MYcWYIlPIww2-qRVlIiN0JgK1WE2WocDW__s7-caidPvA5K1d07AYnTyE_SGKZPO-94_gTtU8hvtnwz75E7hAt6dqoR27bLcds03JrsN_oKxP9GVXgVaz2Xxklq2rbt2OGZeMKuauOxZoZ1lbs-UFCxwdm6ewPDn-ujiNh_IJsZeJ6mIuXJlW3EpuuZd1jr5rveIaL-SVDiU3UtSTT_Iqzby2ua7r0nHhRVYibLX8Gew1bVO9AIZvASV0UjufaXxqbetSoABCOUcfGUE6zqbxA7c4lbj4YQLGKKTpNWBQAyZowKgI3u_uueqZNf4qfURK2kkSK3a4gLZiBlsx_7KVCN6Rig35LnbP2yEFAQdJLFhmLvOc4iWFAzqYSKLP-WnzaCRm8PmNwWCS-NlEoSN4s2umO-kcW1O1W5QRGuNNjMpQ5nlvU7shcS5zLhIegZpY22TM05bm-7fACE4kkBiKR_BhtMtf3frznL78H3P6Ch5kwa_oOMAB7HXrbfUa47TOzeCuWqkZ3Ds6Pv_8BX8t5GIW3BS_l9n8J3fvO9M |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1db9Mw0BqdBLwgvgkMMBKIB4iWxI5TIyG0waaOrRViq7Q3z3acgYSS0qaa-FP8Ru6cpCND7G0PeYkvls_3HfvuCHkJFs4acCNCrlMdciNlaJwBuZIQYCeCiUJg7vB4IkZT_vk4PV4jv7tcGLxW2elEr6jzyuI_8k0w1Vj9ig_lh9nPELtG4elq10KjYYt99-sMQrbF-71PQN9XSbK7c_RxFLZdBUIroqwOGTd57JgWTDMrihRYWtuMSXiROuk7UcSwfBulLk6s1KksitwwbnmSQzSnGcx7jaxzzGgdkPXtncmXr6sQL5FNG10OsRnMx7s0naHYXIC1yDAbGsJ3LOIWZj1T6DsG_GsX_jKMFy9tXji59QZx9za51XqydKthvTtkzZV3yfVxe1Z_jxyC6sGOpTU9rZY11WVOz_x_WNokG9OZL-1ZLt5RTeeunldd1ifFrr3zmvrSt7Qq6PSQ-johi_tkeiWb_YAMyqp0jwgFTZRxGRXGJhJmLXSRcwCAcNLgIwISd7upbFvfHNts_FA-zhkK1VBAAQWUp4DKAvJm9c2sqe5xKfQ2EmkFiZW5_YtqfqpaQVcm0ok2sc05HvDKTOdDZ5g1cWHF0MooIK-RxAr1ByzP6jYNApDESlxqS6Qp-mwZILTRgwS5t_3hjklUq3cW6lxKAvJiNYxf4l260lVLgOESfF7wDAHmYcNTK5QYEynjEQtI1uO2Hs79kfL7N1-VHAtRQjgQkLcdX54v6_97-vhyLJ6TG6Oj8YE62JvsPyE3Ey89ePFggwzq-dI9BY-wNs9aMaTk5Kol_w-5yW3P |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXxJtAKUZC4gBRk9hxYm6lZVUerZDKSr1ZtmOXSlWyymbF32fGedCUh8Qhl3gcxRl_npmM5zMhr8DCWQNuRMx1rmNupIyNM4ArCQF2JpjwAmuHj0_E0ZJ_OsvPrlTxh93uY0qyr2lAlqa621tVvod4KfbWsPIWWFkMoTASosXFTXKLo-nDdK04mEKuDMKLsVTmj_1m5iiw9v--Nl8xTtc3Tl7LngajtLhL7gzeJN3v1X-P3HD1fbJ9POTLH5BTgD-eGtrR82bTUV1X9Ef4F0r7gl-6CvSa9fod1bR1XduMlZcUT85tOxroZ2nj6fKUBq6O9UOyXHz4dnAUD8coxFYkRRczbqrUMS2YZlb4HDCsbcEk3MidDEdvpKAvm-QuzazUufS-MoxbnlUQvmr2iGzVTe2eEAqrQcFl4o3NJDzVa19xEICQzuAlIpKOX1PZgWMcj7q4VCHWKIXqNaBAAypoQBUReTP1WfUMG_-Ufo9KmiSRHTvcaNpzNYBNmURn2qS24phklYWuSmeYNam3orQyichrVLFCDMPrWT2UIsAgkQ1L7Ys8R7-pgAHtzCQBe3bePE4SNWB_rcCpRJ42XsqIvJyasSfuZ6tdswEZLsHvBO8MZB73c2oaEmMiZzxhESlms2025nlLffE9MIMjGSS45BF5O87LX6_192_69P_EX5Dtr4cL9eXjyedn5HYWwIR7AXbIVtdu3HNw0jqzG3D4ExRbMe4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Incident+gout+and+weight+change+patterns%3A+a+retrospective+cohort+study+of+US+adults&rft.jtitle=Arthritis+research+%26+therapy&rft.au=Bai%2C+Lu&rft.au=Zhou%2C+Jian-Bo&rft.au=Zhou%2C+Tao&rft.au=Newson%2C+Roger+B&rft.date=2021-03-02&rft.pub=BioMed+Central+Ltd&rft.issn=1478-6354&rft.volume=23&rft.issue=1&rft_id=info:doi/10.1186%2Fs13075-021-02461-7&rft.externalDocID=A655222376 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1478-6362&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1478-6362&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1478-6362&client=summon |